| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/23/2003 | CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 09/20/2003 | CA2377608A1 Tet-transactivator system |
| 09/19/2003 | WO2002072864A2 Reagents for oligonucleotide cleavage and deprotection |
| 09/19/2003 | CA2468425A1 Reagents for oligonucleotide cleavage and deprotection |
| 09/19/2003 | CA2422583A1 Marburg i mutant of factor vii-activating protease (fsap) as risk factor for arterial thrombosis |
| 09/18/2003 | WO2003076950A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 09/18/2003 | WO2003076949A2 Tagging and recovery of elements associated with target molecules |
| 09/18/2003 | WO2003076940A2 Acyl fluoride activation of carboxysilyl-coated glass substrates |
| 09/18/2003 | WO2003076932A2 Novel method for detecting and analyzing protein interactions in vivo |
| 09/18/2003 | WO2003076899A2 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 09/18/2003 | WO2003076898A2 Mycobacterial diagnostics |
| 09/18/2003 | WO2003076668A2 Method for identifying specific rna-inhibitors |
| 09/18/2003 | WO2003076667A1 Amplification-hybridisation method for detecting and typing human papillomavirus |
| 09/18/2003 | WO2003076664A1 Antisense modulation of jagged 2 expression |
| 09/18/2003 | WO2003076663A1 Detection of proteins interactions |
| 09/18/2003 | WO2003076662A1 Identification of microbial polynucleotides expressed during infection of a host |
| 09/18/2003 | WO2003076661A1 Apparatus and method for amplifying a polynucleotide |
| 09/18/2003 | WO2003076660A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors |
| 09/18/2003 | WO2003076657A2 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes |
| 09/18/2003 | WO2003076643A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/18/2003 | WO2003076642A2 Novel proteins and nucleic acids encoding same |
| 09/18/2003 | WO2003076637A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 09/18/2003 | WO2003076635A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 09/18/2003 | WO2003076634A2 Transcriptional regulation of ptp-1b |
| 09/18/2003 | WO2003076633A2 Inhibition of germination in plants |
| 09/18/2003 | WO2003076632A1 Novel method for the production of hybrid maize seeds |
| 09/18/2003 | WO2003076631A2 Genetic products differentially expressed in tumors and use thereof |
| 09/18/2003 | WO2003076630A1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor |
| 09/18/2003 | WO2003076629A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 09/18/2003 | WO2003076628A1 Scytalone dehydrogenase gene showing tolerance to agricultural pesticide |
| 09/18/2003 | WO2003076627A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 09/18/2003 | WO2003076626A1 Gene participating in the synthesis of brassinosteroid |
| 09/18/2003 | WO2003076625A1 Proteolysis resistant active vegf |
| 09/18/2003 | WO2003076624A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 09/18/2003 | WO2003076623A1 Cdc7-ASK KINASE COMPLEX, SUBSTRATE OF THE KINASE COMPLEX, ANTIBODY SPECIFIC TO THE SUBSTRATE, AND METHOD OF SCREENING COMPOUND CAPABLE OF INHIBITING Cdc7-ASK KINASE USING THE SAME |
| 09/18/2003 | WO2003076622A1 PRESYNAPTIC PROTEIN p120 |
| 09/18/2003 | WO2003076620A1 Methods and means for monitoring and modulating gene silencing |
| 09/18/2003 | WO2003076619A1 Modified gene-silencing rna and uses thereof |
| 09/18/2003 | WO2003076618A1 Reversible toxin and the use thereof |
| 09/18/2003 | WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene |
| 09/18/2003 | WO2003076616A1 Dna encoding lactate dehydrogenase and utilization thereof |
| 09/18/2003 | WO2003076615A1 Novel method of highly sensitive nucleic acid analysis |
| 09/18/2003 | WO2003076612A1 Method of repressing flowering in a plant |
| 09/18/2003 | WO2003076611A1 Alleles of the acea gene from coryneform bacteria |
| 09/18/2003 | WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 09/18/2003 | WO2003076608A1 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 09/18/2003 | WO2003076606A1 High throughput system for producing recombinant viruses using site-specific recombination |
| 09/18/2003 | WO2003076605A1 A method for producing recombinant viruses using site-specific recombination |
| 09/18/2003 | WO2003076601A1 Avian cell lines for the production of useful substances |
| 09/18/2003 | WO2003076598A2 Method of inducing an enhanced immune response against hiv |
| 09/18/2003 | WO2003076597A2 Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof |
| 09/18/2003 | WO2003076596A2 Altering viral tropism |
| 09/18/2003 | WO2003076595A2 Production of insulin and insulin-like proteins in plants |
| 09/18/2003 | WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/18/2003 | WO2003076593A2 Genomic screen for epigenetically silenced genes associated with cancer |
| 09/18/2003 | WO2003076592A2 Novel method for delivery and intracellular synthesis of sirna molecules |
| 09/18/2003 | WO2003076591A2 Compositions and methods for generating an immune response |
| 09/18/2003 | WO2003076583A2 Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria |
| 09/18/2003 | WO2003076581A2 Methods to mediate polyketide synthase module effectiveness |
| 09/18/2003 | WO2003076579A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076574A2 Targeted manipulation of genes in plants |
| 09/18/2003 | WO2003076571A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/18/2003 | WO2003076568A2 Immunotherapeutics for biodefense |
| 09/18/2003 | WO2003076566A2 Enzymatic ligation-based identification of nucleotide sequences |
| 09/18/2003 | WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase |
| 09/18/2003 | WO2003076563A2 Human protooncogene and protein encoded therein |
| 09/18/2003 | WO2003076561A2 Recombinase fusion protein with enhanced cellular uptake |
| 09/18/2003 | WO2003076472A2 Neoplasm specific antibodies and uses thereof |
| 09/18/2003 | WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins |
| 09/18/2003 | WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
| 09/18/2003 | WO2003076467A1 Compositions and methods for inducing and regulating bone formation |
| 09/18/2003 | WO2003076463A2 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance |
| 09/18/2003 | WO2003076462A1 Use of recombinant trypsin for vaccine production |
| 09/18/2003 | WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides |
| 09/18/2003 | WO2003076452A2 Temperature sensitive mutant derivatives of the broad host range plasmid pbhr1 |
| 09/18/2003 | WO2003076412A1 Novel hairpin polyamide |
| 09/18/2003 | WO2003076333A2 Crystalline structure of human mapkap kinase-2 |
| 09/18/2003 | WO2003075952A1 Methods of enhancing immune induction involving mda-7 |
| 09/18/2003 | WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 09/18/2003 | WO2003075944A2 Interferon beta-like molecules for treatment of stroke |
| 09/18/2003 | WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity |
| 09/18/2003 | WO2003075856A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
| 09/18/2003 | WO2003075849A2 Composition and method for enhancing immune response |
| 09/18/2003 | WO2003075844A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 09/18/2003 | WO2003075843A2 Multiple and multivalent dna vaccines in ovo |
| 09/18/2003 | WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/18/2003 | WO2003075840A2 Human antibodies specific to kdr and uses thereof |
| 09/18/2003 | WO2003075838A2 Methods and compositions for pharmacological and toxicological evaluation of test agents |
| 09/18/2003 | WO2003075837A2 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof |
| 09/18/2003 | WO2003075834A2 Activated protein c formulations |
| 09/18/2003 | WO2003075833A2 Screening method for orthopoxvirus antivirals |
| 09/18/2003 | WO2003075747A2 Contrast agents for magnetic resonance imaging and methods related thereto |
| 09/18/2003 | WO2003075670A1 Treatment and prevention of inflammatory disorders |
| 09/18/2003 | WO2003075669A2 Food fermentation with lactic acid bacteria |
| 09/18/2003 | WO2003075655A2 Novel vip3 toxins and methods of use |
| 09/18/2003 | WO2003075648A1 Method of producing cell lines |
| 09/18/2003 | WO2003075647A2 Method and system for in vivo analysis of developmental processes |
| 09/18/2003 | WO2003068815A3 Mhc class ii peptide epitope of 5t4 antigen |